カンザス州における潰瘍性大腸炎の臨床試験
カンザス州内の拠点で、潰瘍性大腸炎に関する10件の研究が参加者を募集しています。
カンザス州内の都市
公式研究テキスト（英語）
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Hutchinson Clinic, Hutchinson
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 006, Kansas City
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07012395A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- University of Kansas Medical Center ( Site 1077), Kansas City
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/28更新 · NCT07463183A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Cotton O'Neil Digestive Health Center, Topeka
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT07196748Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- 他7件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Cotton O'Neil Digestive Health Center, Topeka
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483073A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- University of Kansas Medical Center, Kansas City
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/09/21更新 · NCT06095128A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- University of Kansas Medical Center, Kansas City
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/08/21更新 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- University of Kansas Medical Center - Site Number: 8400110, Kansas City
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- Kansas Gastro, Wichita
被験者募集中
18歳〜85歳 · 全性別 · 2026/08/06更新 · NCT06571669ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。